Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

INCYTE CORP

INCY · Nasdaq · CIK 0000879169 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

93 Form 4 transaction lines observed in the same window
25 sales · 68 option, withholding, award, gift or other lines

Last qualifying purchase2022-03-10 · 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP · $16.0M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Mayes Patrick AEVP & Chief Scientific Officer
○○○○▼○▼○▼
CAGNONI PABLO JPresident, Global Head of R&D
○▼▼▼▼○▼
Stein Steven HCMO & Head of Late-Stage Dev.
○○▼○▼
Tray ThomasPrincipal Accounting Officer
○○○
Issa Mohamed KhairieEVP, Head of U.S. Commercial
○○▼
Gardner David HEVP, Chief Strategy Officer
○○
● Purchase▼ Sale○ Other

Showing the six most active owners; 7 additional owner(s) remain in Form 4 evidence.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2022-03-10 · 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP.

Recent Form 4 activity

0Purchases
46Sales
100Other Form 4 lines
81SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING25 sale line(s) · context only
OTHER68 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
9,987,084
Previous report
9,981,369
Avg daily volume
1,647,341
Days to cover
6.1

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2022-03-10667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)Common Stock218,563USD 73.13USD 15,983,037SEC filing ↗
2022-03-09667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)Common Stock70,517USD 71.72USD 5,057,479SEC filing ↗
2022-03-08667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)Common Stock100,000USD 70.68USD 7,068,000SEC filing ↗
2022-02-22667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)Common Stock99,800USD 68.07USD 6,793,386SEC filing ↗
2022-02-18667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)Common Stock133,032USD 68.38USD 9,096,838SEC filing ↗
2022-02-17667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)Common Stock292,972USD 67.73USD 19,843,441SEC filing ↗
2022-02-14667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)Common Stock502,852USD 66.03USD 33,201,936SEC filing ↗
2022-02-11667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)Common Stock276,507USD 66.82USD 18,474,971SEC filing ↗
2022-02-10667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)Common Stock819,015USD 67.49USD 55,275,240SEC filing ↗
2021-12-17667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)Common Stock1,075,872USD 72.80USD 78,318,365SEC filing ↗
2021-12-16667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)Common Stock169,315USD 71.97USD 12,185,096SEC filing ↗
2021-12-15667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)Common Stock350,332USD 71.51USD 25,052,795SEC filing ↗
2021-02-23Hoppenot HervePurchase (P)Common Stock12,925USD 77.37USD 1,000,007SEC filing ↗
2020-05-28667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)Common Stock1USD 102.55USD 103SEC filing ↗

Form 4 evidence

146 transaction lines in the latest 365-day window; 909 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-01Heeson LeeTax withholding (F)Common Stock463USD 117.14USD 54,236SEC filing ↗
2026-09-30HARRIGAN EDMUNDAward / grant (A)Common Stock206USD 121.35USD 24,998SEC filing ↗
2026-09-30Clancy Paul JAward / grant (A)Common Stock203USD 121.35USD 24,634SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-01Heeson LeeTax withholding (F)Common Stock463USD 117.14USD 54,236SEC filing ↗
2026-09-30HARRIGAN EDMUNDAward / grant (A)Common Stock206USD 121.35USD 24,998SEC filing ↗
2026-09-30Clancy Paul JAward / grant (A)Common Stock203USD 121.35USD 24,634SEC filing ↗
2026-09-30667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPAward / grant (A)Common Stock322USD 0.00USD 0SEC filing ↗
2026-09-22Gardner David HTax withholding (F)Common Stock920USD 126.93USD 116,776SEC filing ↗
2026-09-15CAGNONI PABLO JSale (S)Common Stock23,218USD 120.49USD 2,797,629SEC filing ↗
2026-09-15CAGNONI PABLO JOption exercise / conversion (M)Common Stock23,218USD 66.39USD 1,541,331SEC filing ↗
2026-08-25Basi Ramitpal KTax withholding (F)Common Stock504USD 129.72USD 65,379SEC filing ↗
2026-08-19CAGNONI PABLO JSale (S)Common Stock10,801USD 125.56USD 1,356,174SEC filing ↗
2026-08-12CAGNONI PABLO JSale (S)Common Stock10,803USD 120.04USD 1,296,792SEC filing ↗
2026-08-05Mayes Patrick ASale (S)Common Stock2,207USD 123.99USD 273,646SEC filing ↗
2026-08-05Mayes Patrick AOption exercise / conversion (M)Common Stock2,207USD 106.47USD 234,979SEC filing ↗
2026-08-05CAGNONI PABLO JSale (S)Common Stock10,640USD 122.69USD 1,305,422SEC filing ↗
2026-08-03Mayes Patrick ASale (S)Common Stock6,055USD 120.43USD 729,204SEC filing ↗
2026-08-03Mayes Patrick AOption exercise / conversion (M)Common Stock6,055USD 105.43USD 638,379SEC filing ↗
2026-07-31Mayes Patrick ASale (S)Common Stock41,899USD 119.46USD 5,005,173SEC filing ↗
2026-07-31Mayes Patrick AOption exercise / conversion (M)Common Stock39,712USD 74.37USD 2,953,496SEC filing ↗
2026-07-31CAGNONI PABLO JSale (S)Common Stock15,888USD 119.70USD 1,901,794SEC filing ↗
2026-07-16Tray ThomasAward / grant (A)Common Stock2,834USD 0.00USD 0SEC filing ↗
2026-07-16Stein Steven HSale (S)Common Stock1,877USD 114.73USD 215,348SEC filing ↗
2026-07-16Stein Steven HAward / grant (A)Common Stock9,798USD 0.00USD 0SEC filing ↗
2026-07-16Meury WilliamAward / grant (A)Common Stock26,807USD 0.00USD 0SEC filing ↗
2026-07-16Mayes Patrick AAward / grant (A)Common Stock5,916USD 0.00USD 0SEC filing ↗
2026-07-16Issa Mohamed KhairieSale (S)Common Stock1,093USD 115.01USD 125,706SEC filing ↗
2026-07-16Issa Mohamed KhairieAward / grant (A)Common Stock7,857USD 0.00USD 0SEC filing ↗
2026-07-16Hoffman Richard A.Award / grant (A)Common Stock7,395USD 0.00USD 0SEC filing ↗
2026-07-16Gardner David HAward / grant (A)Common Stock7,395USD 0.00USD 0SEC filing ↗
2026-07-16CAGNONI PABLO JAward / grant (A)Common Stock13,403USD 0.00USD 0SEC filing ↗
2026-07-16Basi Ramitpal KAward / grant (A)Common Stock4,991USD 0.00USD 0SEC filing ↗
2026-07-15Tray ThomasTax withholding (F)Common Stock1,098USD 115.09USD 126,369SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerINCY
CIK0000879169
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC8731 Services-Commercial Physical & Biological Research
ExchangeNasdaq

Data coverage

Local Form 4 history909 transaction lines from 2020-01-02 to 2026-10-01
37 P purchase lines · 195 S sale lines · 677 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.